ID   SBK1_RAT                Reviewed;         417 AA.
AC   Q9Z335; A2RRT7;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   24-JUL-2024, entry version 146.
DE   RecName: Full=Serine/threonine-protein kinase SBK1;
DE            EC=2.7.11.1;
DE   AltName: Full=SH3 domain-binding kinase 1;
GN   Name=Sbk1; Synonyms=Sbk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF LYS-73, FUNCTION, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=Wistar; TISSUE=Hippocampus;
RX   PubMed=11322885; DOI=10.1046/j.1432-1327.2001.02157.x;
RA   Nara K., Akasako Y., Matsuda Y., Fukazawa Y., Iwashita S., Kataoka M.,
RA   Nagai Y.;
RT   "Cloning and characterization of a novel serine/threonine protein kinase
RT   gene expressed predominantly in developing brain.";
RL   Eur. J. Biochem. 268:2642-2651(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May be involved in signal-transduction pathways related to
CC       the control of brain development. {ECO:0000269|PubMed:11322885}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11322885}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in brain, with small amounts in
CC       heart, liver, kidney and heart. {ECO:0000269|PubMed:11322885}.
CC   -!- DEVELOPMENTAL STAGE: Detected in developing brain with a peak at 18
CC       dpc.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB010154; BAA36362.1; -; mRNA.
DR   EMBL; BC131843; AAI31844.1; -; mRNA.
DR   RefSeq; NP_671476.1; NM_147135.2.
DR   RefSeq; XP_008757084.1; XM_008758862.2.
DR   RefSeq; XP_008757086.1; XM_008758864.2.
DR   RefSeq; XP_008758076.1; XM_008759854.2.
DR   RefSeq; XP_017444131.1; XM_017588642.1.
DR   AlphaFoldDB; Q9Z335; -.
DR   SMR; Q9Z335; -.
DR   STRING; 10116.ENSRNOP00000025808; -.
DR   PhosphoSitePlus; Q9Z335; -.
DR   PaxDb; 10116-ENSRNOP00000025808; -.
DR   Ensembl; ENSRNOT00000082228.2; ENSRNOP00000073472.1; ENSRNOG00000067387.1.
DR   Ensembl; ENSRNOT00055053693; ENSRNOP00055044416; ENSRNOG00055030950.
DR   Ensembl; ENSRNOT00060048082; ENSRNOP00060040014; ENSRNOG00060027712.
DR   Ensembl; ENSRNOT00065027071; ENSRNOP00065021273; ENSRNOG00065016268.
DR   GeneID; 113907; -.
DR   KEGG; rno:113907; -.
DR   UCSC; RGD:628713; rat.
DR   AGR; RGD:628713; -.
DR   CTD; 388228; -.
DR   RGD; 628713; Sbk1.
DR   eggNOG; KOG1345; Eukaryota.
DR   GeneTree; ENSGT00940000154852; -.
DR   HOGENOM; CLU_000288_10_1_1; -.
DR   InParanoid; Q9Z335; -.
DR   OMA; LIFCMLT; -.
DR   OrthoDB; 5351614at2759; -.
DR   PhylomeDB; Q9Z335; -.
DR   TreeFam; TF326736; -.
DR   PRO; PR:Q9Z335; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000019082; Expressed in ovary and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   CDD; cd13987; STKc_SBK1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR016234; Ser/Thr_kinase_Sbk1.
DR   PANTHER; PTHR24359; SERINE/THREONINE-PROTEIN KINASE SBK1; 1.
DR   PANTHER; PTHR24359:SF0; SERINE_THREONINE-PROTEIN KINASE SBK1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000566; Ser/Thr_PK_Sbk1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Kinase; Nucleotide-binding; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..417
FT                   /note="Serine/threonine-protein kinase SBK1"
FT                   /id="PRO_0000238453"
FT   DOMAIN          53..318
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          321..405
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        366..390
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        174
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         59..67
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         82
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MUTAGEN         73
FT                   /note="K->M: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11322885"
SQ   SEQUENCE   417 AA;  45676 MW;  C4D36608EE6EE208 CRC64;
     MSVGCPEPEP LHSLPCCGPG AAPVPGAGVP LLTEDMQALT LRTLAASDVT KHYELVRELG
     KGTYGKVDLV AYKGTGTKMA LKFVNKSKTK LKNFLREVSI TNSLSSSPFI IKVFDVVFET
     EECYVFAQEY APAGDLFDII PPQVGLPEDT VKRCVQQLGL ALDFMHSRQL VHRDIKPENV
     LLFDRECRRV KLADFGMTRR VGCRVKRVSG TIPYTAPEVC QAGRADGFAV DTGVDVWAFG
     VLIFCVLTGN FPWEAASGAD AFFEEFVRWQ RGRLPGLPSQ WRRFTEPALR MFQRLLALEP
     ERRGPAKEVF RFLKHELTSE LRRRPSHRAR KPPGDRLPGP LRLEAPGPLK RTVLTESGSG
     SRPSPPSVGP VVPVPVPVPV PVPEAGLAPP APPGRTDGRA DKSKGQVVLA TAIEICV
//
